Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2VAF

Crystal structure of Human Cardiac Calsequestrin

Replaces:  2V0Q
Summary for 2VAF
Entry DOI10.2210/pdb2vaf/pdb
DescriptorCALSEQUESTRIN-2 (1 entity in total)
Functional Keywordscalcium, glycoprotein, polymorphism, muscle protein, disease mutation, sarcoplasmic reticulum, crystal structure human cardiac calsequestrin, metal-binding protein, metal binding protein
Biological sourceHOMO SAPIENS (HUMAN)
Total number of polymer chains1
Total formula weight43997.59
Authors
Kim, E.,Youn, B.,Kemper, L.,Campbell, C.,Milting, H.,Varsanyi, M.,Kang, C. (deposition date: 2007-08-31, release date: 2007-09-11, Last modification date: 2023-12-13)
Primary citationKim, E.,Youn, B.,Kemper, L.,Campbell, C.,Milting, H.,Varsanyi, M.,Kang, C.
Characterization of Human Cardiac Calsequestrin and its Deleterious Mutants.
J.Mol.Biol., 373:1047-, 2007
Cited by
PubMed Abstract: Mutations of conserved residues of human cardiac calsequestrin (hCSQ2), a high-capacity, low-affinity Ca2+-binding protein in the sarcoplasmic reticulum, have been associated with catecholamine-induced polymorphic ventricular tachycardia (CPVT). In order to understand the molecular mechanism and pathophysiological link between these CPVT-related missense mutations of hCSQ2 and the resulting arrhythmias, we generated three CPVT-causing mutants of hCSQ2 (R33Q, L167H, and D307H) and two non-pathological mutants (T66A and V76M) and investigated the effect of these mutations. In addition, we determined the crystal structure of the corresponding wild-type hCSQ2 to gain insight into the structural effects of those mutations. Our data show clearly that all three CPVT-related mutations lead to significant reduction in Ca2+-binding capacity in spite of the similarity of their secondary structures to that of the wild-type hCSQ2. Light-scattering experiments indicate that the Ca2+-dependent monomer-polymer transitions of the mutants are quite different, confirming that the linear polymerization behavior of CSQ is linked directly to its high-capacity Ca2+ binding. R33Q and D307H mutations result in a monomer that appears to be unable to form a properly oriented dimer. On the other hand, the L167H mutant has a disrupted hydrophobic core in domain II, resulting in high molecular aggregates, which cannot respond to Ca2+. Although one of the non-pathological mutants, T66A, shares characteristics with the wild-type, the other null mutant, V76M, shows significantly altered Ca2+-binding and polymerization behaviors, calling for careful reconsideration of its status.
PubMed: 17881003
DOI: 10.1016/J.JMB.2007.08.055
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.8 Å)
Structure validation

246905

PDB entries from 2025-12-31

PDB statisticsPDBj update infoContact PDBjnumon